لابراتوارهای سینادارو
دسینا | Stocks - Tehran Stock Exchange (TSE)
داروهای شیمیایی و گیاهی
Sector:
داروهای شیمیایی و گیاهی
Market Type:
Stocks
Status:
Authorized
Last Price: 92,200 1.60
Close Price: 92,130
Income Statement
AGM
Interim
2026/06/21 Fiscal Year 2026/03/2012 Month | 2025/07/07 Fiscal Year 2025/03/2012 Month | 2024/07/13 Fiscal Year 2024/03/1912 Month | ||
|---|---|---|---|---|
Revenue from Services & Sales | 42.215 Trillion | 24.166 Trillion | 17.342 Trillion | |
Total Revenues | 42.215 Trillion | 24.166 Trillion | 17.342 Trillion | |
Cost of Goods Sold | 17.44 Trillion | 11.017 Trillion | 8.913 Trillion | |
Gross Profit | 24.775 Trillion | 13.148 Trillion | 8.43 Trillion | |
General & Administrative Expenses | 2.511 Trillion | 1.642 Trillion | 1.104 Trillion | |
Net Operating Income & Expenses | 759.085 Billion | 414.307 Billion | 348.281 Billion | |
Operating Profit (Loss) | 23.023 Trillion | 11.921 Trillion | 7.674 Trillion | |
Profit Before Tax | 22.857 Trillion | 11.385 Trillion | 7.177 Trillion | |
Tax | 3.545 Trillion | 1.745 Trillion | 1.542 Trillion | |
Net Profit (Loss) After Tax | 19.311 Trillion | 9.64 Trillion | 5.635 Trillion | |
Retained Earnings at Beginning of Period | 13.086 Trillion | 7.406 Trillion | 4.651 Trillion | |
Prior-Year Adjustments | - | - | -130.374 Billion | |
Approved Dividends — Prior Year AGM | -5.856 Trillion | -3.96 Trillion | -2.88 Trillion | |
Allocable Profit | 26.541 Trillion | 13.086 Trillion | 7.275 Trillion | |
Approved Dividends — Current Year | 13.68 Trillion | 5.856 Trillion | 3.96 Trillion | |
Retained Earnings at End of Period | 12.861 Trillion | 7.23 Trillion | 3.315 Trillion |